loading
전일 마감가:
$2.10
열려 있는:
$2.11
하루 거래량:
3.69M
Relative Volume:
0.95
시가총액:
$568.74M
수익:
$194.75M
순이익/손실:
$-51.26M
주가수익비율:
-7.6589
EPS:
-0.28
순현금흐름:
$-23.38M
1주 성능:
-29.04%
1개월 성능:
-21.25%
6개월 성능:
-10.79%
1년 성능:
+29.52%
1일 변동 폭
Value
$2.07
$2.20
1주일 범위
Value
$2.065
$3.20
52주 변동 폭
Value
$1.52
$4.0787

Akebia Therapeutics Inc Stock (AKBA) Company Profile

Name
명칭
Akebia Therapeutics Inc
Name
전화
617-871-2098
Name
주소
245 FIRST STREET, CAMBRIDGE, MA
Name
직원
181
Name
트위터
@akebiatx
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
AKBA's Discussions on Twitter

AKBA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
AKBA
Akebia Therapeutics Inc
2.145 556.80M 194.75M -51.26M -23.38M -0.28
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.97 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.37 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.16 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
442.77 19.53B 3.08B 1.24B 1.07B 25.61

Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-04 재개 H.C. Wainwright Buy
2025-04-28 개시 Leerink Partners Outperform
2025-04-01 개시 Jefferies Buy
2023-11-29 재개 BTIG Research Buy
2023-08-28 업그레이드 H.C. Wainwright Neutral → Buy
2023-05-31 업그레이드 Piper Sandler Neutral → Overweight
2022-03-31 다운그레이드 H.C. Wainwright Buy → Neutral
2022-03-31 다운그레이드 Mizuho Buy → Neutral
2022-03-31 다운그레이드 Needham Buy → Hold
2022-03-31 다운그레이드 Piper Sandler Overweight → Neutral
2021-03-08 개시 Cantor Fitzgerald Overweight
2021-01-29 다운그레이드 JP Morgan Neutral → Underweight
2019-11-14 재확인 Needham Buy
2019-08-06 재확인 H.C. Wainwright Buy
2019-07-11 재확인 H.C. Wainwright Buy
2019-05-02 개시 JP Morgan Overweight
2019-03-20 개시 Citigroup Neutral
2018-09-07 재개 Morgan Stanley Equal-Weight
2018-08-10 재확인 Needham Buy
2018-06-06 재확인 H.C. Wainwright Buy
2017-12-19 개시 Piper Jaffray Overweight
2017-12-07 개시 BTIG Research Buy
2017-09-15 개시 RBC Capital Mkts Sector Perform
2017-07-10 재확인 H.C. Wainwright Buy
2017-04-27 재확인 H.C. Wainwright Buy
2017-04-27 재확인 Needham Buy
2016-12-27 재확인 H.C. Wainwright Buy
2016-12-20 재확인 JMP Securities Mkt Outperform
2016-11-15 개시 Aegis Capital Buy
2016-09-29 개시 Brean Capital Buy
2016-03-16 재확인 Needham Buy
2016-01-21 개시 Credit Suisse Neutral
모두보기

Akebia Therapeutics Inc 주식(AKBA)의 최신 뉴스

pulisher
08:31 AM

Akebia Therapeutics (NASDAQ:AKBA) Price Target Lowered to $6.00 at HC Wainwright - MarketBeat

08:31 AM
pulisher
06:58 AM

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Tectonic Therapeutic (TECX) and Akebia Therapeutics (AKBA) - The Globe and Mail

06:58 AM
pulisher
06:23 AM

How high can Akebia Therapeutics Inc. stock goWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com

06:23 AM
pulisher
05:31 AM

Akebia Therapeutics (AKBA) Expected to Announce Earnings on Thursday - MarketBeat

05:31 AM
pulisher
04:33 AM

Is Akebia Therapeutics Inc. (AX9) stock attractive for growth fundsJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com

04:33 AM
pulisher
01:50 AM

Can Akebia Therapeutics Inc. stock sustain revenue growth2025 Buyback Activity & Consistent Profit Alerts - newser.com

01:50 AM
pulisher
12:17 PM

Why Akebia Therapeutics Inc. (AX9) stock attracts wealthy investorsJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

12:17 PM
pulisher
12:09 PM

How rising interest rates impact Akebia Therapeutics Inc. stockMarket Activity Report & High Accuracy Buy Signal Tips - newser.com

12:09 PM
pulisher
Oct 30, 2025

Will Akebia Therapeutics Inc. stock attract more institutional investorsWeekly Trade Recap & Weekly Hot Stock Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Akebia Therapeutics Inc. (AX9) stock attractive for dividend growthJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia Therapeutics (AKBA) Is Down 29.9% After Ending VALOR Trial for Non-Dialysis CKD Patients - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia Therapeutics (NASDAQ:AKBA) Price Target Lowered to $5.00 at BTIG Research - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia Therapeutics (NASDAQ:AKBA) Shares Gap DownHere's Why - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

How Akebia Therapeutics Inc. stock trades during market volatilityInsider Buying & Stepwise Trade Signal Guides - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia Therapeutics (AKBA) Receives Revised Price Target from HC Wainwright & Co. | AKBA Stock News - GuruFocus

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

HC Wainwright & Co. Maintains Akebia Therapeutics (AKBA) Buy Recommendation - Nasdaq

Oct 30, 2025
pulisher
Oct 30, 2025

How strong dollar benefits Akebia Therapeutics Inc. (AX9) stock2025 Big Picture & Fast Gain Swing Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Strategic Shift and Market Opportunities Drive Buy Rating for Akebia Therapeutics - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Is Akebia Therapeutics Inc. (AX9) stock undervalued at current priceMarket Rally & Smart Money Movement Tracker - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Akebia price target lowered to $6 from $8 at H.C. Wainwright - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Will Akebia Therapeutics Inc. stock benefit from sector rotationJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Will Akebia Therapeutics Inc. (AX9) stock profit from AI boomTrade Risk Report & AI Based Buy and Sell Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Health Care Down on Mixed EarningsHealth Care Roundup - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

BTIG Lowers Akebia Therapeutics (AKBA) Price Target by 50% | AKB - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Why Is Akebia Therapeutics Stock Plunging TodayAkebia Therapeutics (NASDAQ:AKBA) - Benzinga

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core (NASDAQ:AKBA) - Seeking Alpha

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia Therapeutics’ Pediatric Anemia Study Withdrawn: Market Implications - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia stock plunges as kidney drug expansion plans scrapped - The Business Journals

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia scraps plan for Vafseo trial after discussions with FDA - Fierce Pharma

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion - Stocktwits

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia stock tumbles after FDA meeting on vadadustat trial design By Investing.com - Investing.com Canada

Oct 29, 2025
pulisher
Oct 29, 2025

Akebia Abandons Non-Dialysis Trial For Vafseo On Likely Higher Costs - Citeline News & Insights

Oct 29, 2025
pulisher
Oct 29, 2025

Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Oct 29, 2025
pulisher
Oct 29, 2025

Morning Market Movers: CMBM, LRN, VRNS, AKBA See Big Swings - RTTNews

Oct 29, 2025
pulisher
Oct 29, 2025

FDA setback prompts Akebia to give up on broader Vafseo label - The Pharma Letter

Oct 29, 2025
pulisher
Oct 29, 2025

Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 29, 2025
pulisher
Oct 29, 2025

Will earnings trigger a reversal in Akebia Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why institutional investors increase stakes in Akebia Therapeutics Inc. (AX9) stockAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Analyzing Akebia Therapeutics Inc. with risk reward ratio chartsPortfolio Return Report & Community Trade Idea Sharing - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Comparing Akebia Therapeutics Inc. in custom built stock radarsExit Point & AI Driven Price Predictions - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Is Halting Broad Vafseo Expansion Shifting the Investment Outlook for Akebia Therapeutics (AKBA)? - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics (AKBA) Halts Expansion Plans for Vafseo - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia (AKBA) Adjusts Strategy Following FDA Meeting on Anemia T - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Beat: Will Akebia Therapeutics Inc. stock benefit from sector rotationMarket Performance Recap & Technical Pattern Alert System - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia plummets as it abandons Vafseo for non-dialysis patients - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics tumbles after FDA setback on anemia drug trial - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics Halts VALOR Trial for Vadadustat - TipRanks

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics provides update on Vafseo for non-dialysis patients - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics Inc Updates on Vafseo Clinical Trial Plans - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients - The Manila Times

Oct 28, 2025

Akebia Therapeutics Inc (AKBA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$45.39
price up icon 3.40%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.23%
$22.48
price down icon 0.51%
$10.34
price down icon 0.29%
$141.75
price up icon 2.75%
$444.10
price down icon 2.19%
자본화:     |  볼륨(24시간):